Posts by: Marta Figueiredo

Marta Figueiredo

Marta Figueiredo holds a BSc in Biology and a MSc in Evolutionary and Developmental Biology from the University of Lisbon, Portugal. She is currently finishing her PhD in Biomedical Sciences at the University of Lisbon, where she focused her research on the role of several signalling pathways in thymus and parathyroid glands embryonic development.

December 19, 2019December 19, 2019

CBD Complements Clobazam to Prevent Seizures in Distinct Ways, Early Study Suggests

uncategorized

Combining cannabidiol (CBD) with clobazam — a well-known treatment for childhood epilepsies like Lennox‑Gastaut syndrome (LGS) — leads to greater anti-seizure effects, but only when given at its therapeutic dose, a ... Read more

December 12, 2019December 12, 2019

Epidiolex-Clobazam Interaction May Explain Reductions in Seizures, Study Suggests

News

Epidiolex-associated reduction in the frequency of drop seizures may be caused by an interaction between its active component — cannabidiol (CBD) — and clobazam, a well-known anti-seizure medication, according to a recent ... Read more

November 7, 2019November 14, 2019

Enrollment Completed in Phase 3 Trial Testing Fintepla to Treat Seizures in Lennox-Gastaut Syndrome Patients

News

Zogenix has enrolled the last patient in a Phase 3 clinical trial evaluating its lead investigational candidate Fintepla (ZX008) as an add-on therapy for seizures associated with Lennox‑Gastaut syndrome (LGS), the company ... Read more